Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis

Journal of Autoimmunity

Volumn 26, Issue 2, 2006, Pages 138-145

  Nakamura, Minoru ^a   Takii, Yasushi ^a   Ito, Masahiro ^a   Komori, Atsumasa ^a   Yokoyama, Terufumi ^a   Shimizu Yoshida, Yuki ^a   Koyabu, Makiko ^a   Matsuyama, Mutsumi ^b   Mori, Tsuyoshi ^a   Kamihira, Takashi ^a   Daikoku, Manabu ^a   Migita, Kiyoshi ^a   Yatsuhashi, Hiroshi ^a   Nozaki, Naohito ^c   Shimoda, Shinji ^d   Ishibashi, Hiromi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c KANAGAWA DENTAL COLLEGE   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Biliary epithelial cells; gp210; Monoclonal antibody; Primary biliary cirrhosis; Small bile duct

Indexed keywords

CELL NUCLEUS ANTIGEN; GP210 ANTIGEN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE HEPATITIS; BILE DUCT; CELL NUCLEUS MEMBRANE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; ANTIBODIES; ANTIBODIES, MONOCLONAL; BILE CANALICULI; BIOPSY, NEEDLE; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER FAILURE; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NUCLEAR PORE COMPLEX PROTEINS; NUCLEAR PROTEINS; PROGNOSIS;

EID: 31344445698     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2005.10.007     Document Type: Article

References (47)

1. E. Rubin, F. Schaffner, and H. Popper Primary biliary cirrhosis Am J Pathol 46 1965 387 407
2. P.S.C. Leung, R.L. Coppel, A. Ansari, S. Munoz, and M.E. Gershwin Antimitochondrial antibodies in primary biliary cirrhosis Semin Liver Dis 17 1997 61 69
3. J.C. Couvalin, and H.J. Worman Nuclear envelope protein autoantibodies in primary biliary cirrhosis Semin Liver Dis 17 1997 79 90
4. C. Szostecki, H.H. Guldner, and H. Will Autoantibodies against nuclear dots in primary biliary cirrhosis Semin Liver Dis 17 1997 71 78
5. S. Itoh, T. Ichida, T. Yoshida, A. Hayakawa, M. Uchida, and T. Tashiro-Itoh Autoantibodies against a 210kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis J Gastroenterol Hepatol 13 1998 257 265
6. P. Invernizzi, M. Podda, P.M. Battezzati, A. Crosignani, M. Zuin, and E. Hitchman Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis J Hepatol 34 2001 366 372
7. P. Muratori, L. Muratori, R. Ferrari, F. Cassani, G. Bianchi, and M. Lenzi Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis Am J Gastroenterol 98 2003 431 437
8. P. Invernizzi, J. Wesierska-Gadek, P.M. Battezzati, S. Oertelt, P.L. Busatto, and A. Benetti Prognostic value of autoantibodies against proteins of nuclear pore complexes (anti-NPCs) in early primary biliary cirrhosis (PBC) J Hepatol 40 2004 159 160 (abstract)
9. M. Nakamura, Y. Shimizu-Yoshida, Y. Takii, A. Komori, T. Yokoyama, and T. Ueki Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis J Hepatol 42 2005 386 392
10. P.J. Scheuer Primary biliary cirrhosis Proc R Soc Med 60 1967 1257 1260
11. C. Corpechot, F. Carrat, R. Poupon, and R.E. Poupon Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients Gastroenterology 122 2002 652 658
12. R.E. Poupon, K.D. Lindor, A. Pares, O. Chazouilleres, R. Poupon, and E.J. Heathcote Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis J Hepatol 39 2003 12 16
13. G. Toda, M. Zeniya, F. Watanabe, M. Imawari, K. Kiyosawa, and M. Nishioka Present status of autoimmune hepatitis in Japan - correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japan National Study Group of Autoimmune Hepatitis J Hepatol 26 1997 1207 1212
14. S. Shimoda, M. Nakamura, H. Ishibashi, K. Hayashida, and Y. Niho HLA DRB4 0101-restricted immunodominant T-cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases J Exp Med 181 1995 1835 1845
15. K. Kimura, N. Nozaki, M. Saijo, A. Kikuchi, M. Ui, and T. Enimoto Identification of the nature of modification that causes the shift of DNA topoisomerase IIb to apparent higher molecular weight forms in the M phase J Biol Chem 269 1994 24523 24526
16. S. Shimoda, J. Van de Water, A. Ansari, M. Nakamura, H. Ishibashi, and R.L. Coppel Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis J Clin Invest 102 1998 1831 1840
17. H. Kita, S. Matsumura, X.S. He, A.A. Ansari, Z.X. Lian, and J. Van de Water Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis J Clin Invest 109 2002 1231 1240
18. T. Kamihira, S. Shimoda, M. Nakamura, T. Yokoyama, Y. Takii, and A. Kawano Biliary epithelial cells regulate autoreactive T cells: implication for biliary-specific diseases Hepatology 41 2005 151 159
19. K. Harada, J. Van de Water, P.S. Leung, R.L. Coppel, A. Ansari, and Y. Nakanuma In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the TH1 subset Hepatology 25 1997 791 796
20. K. Tsuneyama, K. Harada, N. Kono, M. Sasaki, T. Saito, and M.E. Gershwin Damaged interlobular bile ducts in primary biliary cirrhosis show reduced expression of glutathione-S-transferase-pi and aberrant expression of 4-hydroxynonenal J Hepatol 37 2002 176 183
21. H. Koga, S. Sakisaka, M. Ohishi, M. Sata, and K. Tanikawa Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis Hepatology 25 1997 1077 1084
22. K. Harada, S. Ozaki, E. Gershwin, and Y. Nakanuma Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis Hepatology 26 1997 1399 1405
23. M. Jaiswal, N.F. LaRusso, R.A. Shapiro, T.R. Billiar, and G.J. Gores Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes Gastroenterology 120 2001 190 199
24. A. Celli, F.G. Que, G.J. Gores, and N.F. LaRusso Glutathione depletion is associated with decreased Bcl-2 expression and increased apoptosis in cholangiocytes Am J Physiol 275 1998 G749 G757
25. C.-T. Wu, J.P. Eiserich, A.A. Ansari, R.L. Coppel, S. Balasubramanian, and C.L. Bowlus Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions Hepatology 38 2003 1018 1025
26. K. Harada, S. Furubo, S. Ozaki, K. Hiramatsu, Y. Sudo, and Y. Nakanuma Increased expression of WAF1 in intrahepatic bile ducts in primary biliary cirrhosis relates to apoptosis J Hepatol 34 2001 500 506
27. J.C. Courvalin, K. Lassoued, E. Bartnik, G. Blobel, and R.W. Wozniak The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore J Clin Invest 86 1990 279 285
28. R.E. Nickowits, and H.J. Worman Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein gp210 J Exp Med 178 1993 2237 2242
29. F. Tartakovsky, and H.J. Worman Detection of gp210 autoantibodies in primary biliary cirrhosis using a recombinant protein containing the predominant autoepitope Hepatology 21 1995 495 500
30. O. Bandin, J.-C. Courvalin, R. Poupon, L. Dubel, J.-C. Homberg, and C. Johanet Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis Hepatology 23 1996 1020 1024
31. J. Wesierska-Gadek, H. Hohenauer, E. Hitchman, and E. Penner Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210 J Exp Med 182 1995 1159 1162
32. J. Wesierska-Gadek, H. Hohenauer, E. Hitchman, and E. Penner Anti-gp210 antibodies in sera of patients with primary biliary cirrhosis. Identification of a 64kD fragment of gp210 as a major epitope Hum Antibodies Hybridomas 7 1996 167 174
33. W. Antonin, C. Franz, U. Haselmann, C. Antony, and I.W. Mattaj The integral membrane nucleoporin pom121 functionally links nuclear pore complex assembly and nuclear envelope formation Mol Cell 17 2005 83 92
34. C. Eriksson, C. Rustum, and E. Hallberg Dynamic properties of nuclear pore complex proteins in gp210 deficient cells FEBS Lett 572 2004 261 265
35. S.P. Drummond, and K.L. Wilson Interference with the cytoplasmic tail of gp210 disrupts "close apposition" of nuclear membranes and blocks nuclear pore dilation J Cell Biol 158 2002 53 62
36. M. Olsson, S. Scheele, and P. Ekblom Limited expression of nuclear pore membrane glycoprotein 210 in cell lines and tissues suggest cell-type specific nuclear pores in metazoans Exp Cell Res 292 2004 359 370
37. M. Olsson, M.A. English, J. Mason, J.D. Licht, and P. Ekblom Despite WT1 binding sites in the promoter region of human and mouse nucleoporin glycoprotein 210, WT1 does not influence expression of GP210 J Negat Results Biomed 3 2004 1612 1637
38. T. Hanafusa, R. Pujol-Borrel, L. Chiovato, R.C. Russell, D. Doniach, and G.F. Bottazzo Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity Lancet 12 1983 1111 1115
39. J. Van de Water, J. Turchany, P.S. Leung, J. Lake, S. Munoz, and C.D. Surh Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2 J Clin Invest 91 1993 2653 2664
40. K. Harada, J. Van de Water, P.S.C. Leung, R.L. Coppel, Y. Nakanuma, and M.E. Gershwin In situ nucleic acid hybridization of pyruvate dehydrogenase complex-E2 in primary biliary cirrhosis: pyruvate dehydrogenase complex-E2 messenger RNA is expressed in hepatocytes but not in biliary epithelium Hepatology 25 1997 27 32
41. T.A. Ferguson, P.M. Stuart, J.M. Hemdon, and T.S. Griffith Apoptosis, tolerance, and regulatory T cells-old wine, new wineskins Immunol Rev 193 2003 111 123
42. J.A. Odin, R.C. Huebert, L. Casciola-Rosen, N.F. LaRusso, and A. Rosen Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis J Clin Invest 108 2001 223 232
43. P. Macdonald, J. Palmer, J.A. Kirby, and D.E.J. Jones Apoptosis as a mechanism for cell surface expression of the autoantigen pyruvate dehydrogenase complex Clin Exp Immunol 136 2004 559 567
44. H. Shigematsu, S. Shimoda, M. Nakamura, S. Matsushita, Y. Nishimura, and N. Sakamoto Fine specificity of T cells reactive to human PDC-E2 163-176 peptide, the immunodominant autoantigen in primary biliary cirrhosis: implications for molecular mimicry and cross-recognition among mitochondrial autoantigens Hepatology 32 2000 901 909
45. S. Shimoda, M. Nakamura, H. Ishibashi, A. Kawano, T. Kamihira, and N. Sakamoto Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis Gastroenterology 124 2003 1915 1925
46. C. Degott, E.S. Zafrani, P. Callard, B. Balkau, R.E. Poupon, and R. Poupon Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression Hepatology 29 1999 1007 1012
47. C. Corpechot, F. Carrat, A. Bahr, Y. Chretien, R.E. Poupon, and R. Poupon The effect of ursodeoxycholic acid therapy on natural course of primary biliary cirrhosis Gastroenterology 128 2005 297 303